Reading Past the First Line

A gene is a letter, not a verdict. An obituary from the San Luis Valley, and the story medicine keeps refusing to tell.

Photo by Adrian Avila on Unsplash

I read the obituaries. I always have. For seventeen years I kept a private practice in the four corners of the US, caring for hundreds of families — some of them across three and four generations — and even now, eight years gone from the valley, I still feel a quiet stewardship toward those names and faces. They are not strangers to me. So when one of them surfaces in the paper, I read it the way you read a letter from someone you once loved. This week one of them stopped me.

A man of forty-two, from the San Luis Valley in southern Colorado — ancient Spanish and Mexican lineage, roots sunk deep into that high red basin cradled between the Sangre de Cristo and the San Juan ranges — died of what the paper called “complications of Recombinant chromosome 8 syndrome.” A genetic disease. The phrasing carried its usual quiet verdict: this was written into him at conception, a biological fate he was simply living out on schedule.

I read it twice. And what rose in me was not grief exactly, though there was tenderness. It was the older ache of watching a life get explained away by a single word — and watching that word do what it always does, which is close the conversation instead of open it. We are still telling this story so wrong.

Not his story alone. All of it. We have made “genetic” into a period at the end of a sentence when it has always, always been a question mark. We wrap tragedy in the language of inevitability because inevitability asks nothing of us. It does not send us looking at the water, or the soil, or the slow withdrawal of everything that once kept a body whole. It lets us grieve without having to change a thing. And the real story — the terrain story, the one where there is still something to be done — goes into the ground unspoken alongside the man.

He was forty-two. He lived in a valley with contaminated wells, in a population carrying documented methylation vulnerabilities, drinking from groundwater measurably loaded with fluoride, arsenic, and uranium as decades of drought pulled the water table down into the strata where those poisons concentrate. And the obituary said: it was his genes. I cannot let that stand without saying something. I never have been able to. It is, for better and worse, the thing that has shaped my whole strange career — this inability to stay quiet when the official story leaves out the part that might have actually mattered.

Photo by Google DeepMind on Unsplash

Genes Are the Last Stop, Not the First

Here is what most of medicine still gets backward, and what people handed a genetic “sentence” most need to hear: a mutation is almost never where the collapse begins. It is where the collapse ends up. It is the place the body finally runs out of road.

Consider the genes that get all the press — BRCA1, BRCA2, ATM, MLH1, MSH2, GATA2, and TP53, the so-called Li-Fraumeni gene. These are the names that drop a trapdoor under a person the moment they surface on a panel. The ones translated, by well-meaning oncologists, into lifetime surveillance, prophylactic surgery, and the unspoken sentence underneath it all: you are now a clock, and you are ticking.

But let’s look at what these genes actually do for a living.

The BRCA genes build proteins that repair double-strand breaks in your DNA. ATM — Ataxia Telangiectasia Mutated — is the alarm system that mobilizes the cell when the genome comes under threat. MLH1 and MSH2 are the proofreaders, catching replication errors before they spread. GATA2 governs cell differentiation and immune function. TP53 is the gatekeeper, standing at the threshold of every stressed cell and deciding, in real time: repair this, or shut it down.

Not one of these genes causes cancer. What they do is run the repair shop. And when the repair shop is already overwhelmed — when the terrain it serves is drowning in oxidative stress, nutritional depletion, toxic burden, hormonal chaos, and the epigenetic static of environmental poison — those repair systems get pushed past what they can hold. The gene did not author the failure. The gene was the last light still on in the building when the failure finally came.

This is not a semantic quibble. It is the whole difference between spending a life braced against an inherited verdict and spending that life tending the conditions that decide whether the verdict is ever read aloud.

Photo by Remy Olson on Unsplash

The Specific Tragedy of the San Luis Valley

Let me bring this back to the valley, because I know few cleaner examples of terrain being erased from the record in favor of genetic blame. This valley is sacred to me — its hot springs, its fireflies, the camping trips and long immersions in its wild that have fed my own healing and my own joy for decades. I am not writing about it from a distance. I am writing about a place that has held me.

Recombinant chromosome 8 syndrome — once called, plainly, San Luis Valley syndrome — is a rare chromosomal condition traced largely to families of Spanish and Mexican descent in that region. The literature describes it as a structural rearrangement of chromosome 8, a mechanical mishap during meiosis that leaves an imbalance of genetic material and a cascade of consequences: congenital heart defects, developmental challenges, kidney anomalies. Medicine names it genetic, attributes it to a “founder effect” in an isolated ancestral population, and closes the file. Genetic. Inevitable. Done. But chromosomes do not fold and loop and break in a vacuum.

The stability of DNA during cell division — including meiosis, the making of eggs and sperm — is shaped continuously by the chemistry surrounding it. The chromatin that organizes the genome, the methylation tags that decide how tightly it coils, the enzymatic machinery that ushers it through division: all of it answers to the state of the terrain. And halides like fluoride, and heavy metals like arsenic, are well-documented saboteurs of exactly the methylation machinery that keeps this process honest.

Here is where it gets specific. The valley sits on volcanic rock whose weathering has fed the confined aquifer geogenic fluoride, arsenic, and uranium for centuries. As the drought deepens and the water table falls, what remains is drawn from deeper strata where those contaminants concentrate. Research from the Colorado School of Public Health has found elevated heavy metals in roughly one in four private wells in the region. These are the wells families drink from every single day — Hispanic families carrying MTHFR variants common to their ancestry, families carrying generational chromosomal inversions, drawing their water from poisoned ground.

MTHFR — methylenetetrahydrofolate reductase — runs the central methylation cycle. A variant here, present at notably high rates in Hispanic populations, causes no disease on its own. For hundreds of years it caused nothing; it is a natural variation, likely adaptive in its first context. The trouble begins when you set a methylation engine that already runs lean on top of a terrain under constant methyl-stealing assault — arsenic detoxification draining the tank, fluoride jamming the enzymes meant to refill it. The cycle buckles. DNA repair goes dark. Epigenetic signaling misfires.

A population with MTHFR vulnerability, drinking water that strips its methyl donors and poisons the enzymes that replenish them, carrying chromosomal inversions that grow less stable as the cellular environment degrades — that is not a genetic-disease story. That is a terrain story, blamed on genes because the blame is so much more convenient for everyone holding institutional power. The aquifer never has to answer for itself. The genes always do.

The Same Story, in Better Shoes

Trigger warning, because being careful here would be its own kind of lie. I am not interested in being careful. I am interested in being the messenger — and the messenger is rarely the most welcome person in the room. So: it would be easy to read all of this as a story about poverty and rural neglect, about the people downstream of contaminated wells who never had the resources to test their water. That story is real. But it is only half of what I see, and the other half wears better shoes.

Some years ago I was in San Diego for an integrative oncology conference, and between sessions I wandered into an Anthropologie store. A young woman on staff asked what brought me to town. I told her. And what happened next I have never forgotten: a small cluster of these bright, seemingly healthy young women gathered around me, almost in solidarity, to tell me about a colleague who was out that week — recovering from a double mastectomy and reconstruction, they explained, to “manage her BRCA gene.”

They told me this with real tenderness for their friend. And every one of them was talking to me with her cell phone tucked into her bra.

I stood there holding both things at once. A woman their age had just had healthy breast tissue surgically removed to outrun a gene — and not one of these young women had ever been invited to wonder what it means that the most hormonally dynamic, proliferative tissue in their own bodies spends its days pressed against a phone. We will counsel amputation as prevention and say nothing about the daily, intimate exposures we have never bothered to study. I am not claiming the phone in the bra is the cause of anything. I am saying nobody had even handed these women the question — and the absence of the question is itself the disease.

I could not not say something. They looked at me as though I had grown nine eyes. But here is what I needed them to hear, and what I need you to hear, because the science underneath that moment is not soft at all.

The genes we fear most — BRCA, the Lynch genes, ATM — are DNA-repair genes. They are, by their very job description, the genes most vulnerable to ionizing radiation, because radiation works by breaking DNA, and these are precisely the systems that have lost some of their capacity to repair those breaks. This is not fringe speculation. The International BRCA1/2 Carrier Cohort Study found that reported chest X-ray exposure was associated with a significantly increased risk of breast cancer in carriers — an increase that appears to exceed, several times over, what is seen in other radiation-exposed populations. The GENE-RAD-RISK study found that diagnostic radiation before the age of thirty raised breast cancer risk in carriers. Carriers even show measurably increased chromosomal radiosensitivity in the laboratory.

And yet the standard counsel for these same women is a lifetime of the one thing their cells are least equipped to absorb — repeated mammographic radiation of tissue we already know to be radiosensitive, every six months, in the name of catching early what we may be helping to create. Read that twice. We are irradiating, on a schedule, the very population whose defining biological feature is an impaired ability to repair radiation damage. That is not prevention. That is a system following its own protocol straight past the biology it claims to serve.

The surgery deserves the same honesty. I have sat with women who did everything they were told — who removed the breasts, removed the ovaries, did the radical, disfiguring, courageous thing in good faith — and developed cancer anyway, years later, sometimes in the very chest wall where the tissue used to be. The research bears this out: residual fibroglandular tissue remains in more than ninety percent of breasts after mastectomy, and the risk is reduced but never brought to zero. Removing the body part does not remove the terrain. A gene does not live in a breast. It lives in every cell you have left.

And here is the part that ought to change how this whole conversation is held: BRCA status, in study after study, does not significantly alter overall survival. Carriers do tend to develop cancer younger and face higher contralateral risk — that is true and worth respecting. But the gene itself is not the executioner the fear makes it out to be. I had a consult just yesterday with a woman carrying a Li-Fraumeni process, told flatly by her conventional team that she is a sitting duck — a phrase that should be malpractice to say to a human being — when the evidence simply does not support the sentence she was handed. She is not a sitting duck. She is a woman with a thinner margin in one specific system, and a great deal of terrain still under her own authority. No one had told her that. Someone should have. It might as well be me.

Why Medicine Keeps Telling the Wrong Story

Photo by Anne Nygård on Unsplash

It would be comforting to believe genetic determinism persists by accident. It does not. It persists because it serves a system, and we ought to be willing to name how.

When disease is framed as inherited inevitability, the environment is quietly let off the hook. No one has to answer for the collapsed aquifer. No one has to fund filtration for low-income rural families. No one has to ask what arsenic at twice the EPA limit does to a methylation-compromised population across decades of daily exposure. The “bad gene” story is extraordinarily convenient for everyone except the people dying inside it. It is, to use a word I try to ration, bullshit — and it is expensive bullshit, paid for in lives.

It does something to the patient, too. It quietly trades your agency for a prescription. If you are broken at the level of the code, the only rational posture is managed decline — so why bother with the testing, the nutrition, the toxin reduction, the slow advocacy of terrain work, if your DNA is running the table anyway? Determinism does not merely misdescribe the body. It demobilizes the person living inside it.

I have watched this scene play out for more than two decades. Someone arrives clutching a fresh BRCA result, or a Lynch panel, or an ATM variant, already told — out loud or between the lines — that they are now a sitting duck whose only remaining job is surveillance. The language of real prevention, terrain prevention, almost never makes it into the room. And the cruelest irony is this: the genes that most reliably trigger panic are often the ones most responsive to how you tend the terrain around them. Not because you can rewrite the letters. Because the conditions for their worst expression can be actively, daily, stubbornly disrupted. The gap between the gene and the outcome — that gap is where we live. And it is enormous.

What Your Genes Are Actually Trying to Tell You

So here is the reframe I want you to carry out of this essay and into your own body: your genes are messengers. They are not executioners. They are not a sentence. They are a letter — and most people have never been taught to read past the first line.

A BRCA mutation is not telling you that cancer is your destiny. It is telling you that your DNA-repair crew is working with reduced backup, and needs more from you than the next person needs — more nutritional cofactors, more toxin reduction, more hormonal balance, more real sleep, more nervous-system steadiness. It is a call to be more deliberate, not a date stamped at birth.

An MTHFR variant is not a defect. It is a signal that your methylation cycle bruises more easily, and that you would do well to notice what keeps stealing your methyl donors — processed food, alcohol, certain medications, heavy metals, mold, and the water coming out of your own tap.

MLH1 and MSH2, in a Lynch context, are not a guarantee of colorectal or endometrial cancer. They are telling you the proofreading system benefits from an especially clean terrain — one where the mutational pressure of poor diet, microbial disruption, inflammation, and chemical exposure is kept low enough that those editors are never overwhelmed before they can do their work.

Li-Fraumeni — TP53 mutations that make the gatekeeper less reliable — is genuinely serious, and I will not pretend otherwise to anyone. But even here, the research on metabolic health, lifestyle, and environmental burden shows real influence on whether and how that risk expresses. The message is not “give up.” The message is: your quality control needs every ally it can get, so be one.

ATM, GATA2, the mismatch-repair complex — each is saying the same thing in a different dialect. This is where your system runs thin. So tend it harder, right here.

Test, Assess, Address. Don’t Guess.

I am not going to leave you in the clouds. The whole point of terrain work is that it lands somewhere specific and testable. This is the framework I have leaned on for over thirty years, and it begins exactly where the fear wants you to end.

Know your terrain precisely. A genetic variant is not the close of the conversation — it is the opening line. Get the labs that actually show you your terrain: methylation markers like homocysteine and methylmalonic acid; toxic burden through a comprehensive heavy-metals panel, and mycotoxins where indicated; nutritional status across B vitamins, vitamin D, zinc, magnesium, and your omega-3 index; inflammatory load through hs-CRP, ferritin, and fibrinogen; and metabolic function through fasting glucose, fasting insulin, and HbA1c. These are the levers you can move. A genetic result without a functional terrain map is like being told your engine runs lean and never once checking the fuel.

Know your water. If you draw from a private well you cannot assume it is safe. For those in the US, the Environmental Working Group keeps a free, searchable tap-water database at ewg.org; it is a reasonable first look before you ever pay for a test. From there, have your water tested independently, and not only on the standard municipal panel but specifically for arsenic, uranium, fluoride, nitrates, and heavy metals. The EPA’s maximum contaminant levels are not optimal health thresholds, and for private wells they are not enforced at all. The space between “legal” and “safe” is where a great deal of silent damage accumulates. Point-of-use reverse osmosis is the most effective option if you find contamination. And do not boil and hope — boiling concentrates heavy metals, it does not remove them.

Feed your methylation through how you live. If you carry an MTHFR variant, the daily question is less about any single pill and more about whether your ordinary life is feeding that cycle or starving it. Methyl donors come first from the table — folate-rich leafy greens and vegetables, clean protein, the B-vitamin-dense whole foods our great-grandmothers ate without a second thought. And the methyl thieves are worth naming just as plainly: alcohol, ultra-processed food, chronic unrelenting stress, broken sleep, and the toxic burden we have already discussed. Before anyone reaches for a protocol, the more honest work is to look at what the rhythm of a normal week is doing to a cycle that already runs lean. The terrain is built far more in the kitchen, the bedroom, and the nervous system than in the supplement aisle.

Reduce your exposome. The exposome — the sum total of what your body has to process from the world — is your most actionable lever of all. Water, air, food sourcing, product ingredients, medication load, and the invisible freight we absorb through personal care, cookware, and the very buildings we live in. And it includes, without apology, the chronic stressors of a life. The epigenome does not distinguish between arsenic and unprocessed grief; both register as signals worth mounting a defense against. The body keeps its ledger in the methylation cycle, and everything goes on the books.

Push back, constructively, on your care team. You are allowed to ask what is driving this expression, not only what it is named. You are allowed to ask about environmental contributors, nutritional status, methylation function, and burden reduction alongside whatever genetic information you are handed. If your provider’s entire answer to a genetic result is surveillance and medication, you have not reached the end of the road. You have reached the end of their training. The next question is yours to ask.

Find your people. One of the most underrated tools in all of terrain medicine is the dismantling of isolation. Shame, secrecy, the private conviction that you are uniquely and irreparably broken — all of which the determinism narrative quietly cultivates — are themselves epigenetic inputs. The science on connection, meaning, and the nervous system’s role in immune function and gene expression is not soft. It is mechanistic. Find your people. Tell your story out loud. The stories we tell about our bodies become part of the terrain those bodies have to live in.

Photo by Gildardo RH on Unsplash

Tend the Terrain

The man in that obituary was forty-two. He came from a lineage that survived centuries in one of the most demanding landscapes in North America — thin air, brutal winters, deep isolation. His ancestors carried those same chromosomes across generation after generation without dying at forty-two, because the terrain they lived in, imperfect as it was, still supported the expression of resilience.

Then the terrain changed. The water changed. Industrial agriculture hollowed out the soil his food grew in. The slow violence of environmental neglect and absent infrastructure altered the epigenetic signaling in his cells from the time he was in the womb. And his genome — his messenger, never his executioner — did precisely what it was built to do. It compensated, and compensated, and compensated, until one day it could not anymore. That is not a genetic disease. That is a terrain disease wearing a genetic face. And we will keep losing people to it for exactly as long as we accept the genetic label as the whole explanation instead of the opening of a much harder set of questions.

What questions? Who answers for the water in private wells that fall outside every layer of municipal oversight? Why are MTHFR variants discussed as a matter of individual supplement protocols rather than population-level exposure? Why does a community’s genetic heritage get blamed for outcomes that decades of terrain assault helped author? Who benefits from that framing — and who pays for it?

These are the questions that belong in the comments of every genetic counseling session, in the editorial reply to every obituary that blames a chromosome, in every policy conversation about aquifers and rural environmental justice. They are the questions I am bringing here, into this space, because the exam room is too often too small to hold them.

Your genes are not your destiny. They are responsive instruments, waiting on the signals you feed them. You cannot rewrite the sequence you were born into — but you hold far more authority over the conditions of its expression than anyone has likely ever told you. That authority is not a mood or a mantra. It is a practice. It is, I would argue, the most direct act of sovereignty available to you, here, in a body that is listening to everything you do, and everything you fail to do, and answering accordingly.

That is what it means to tend the terrain. Not as metaphor. As the work.

What rises in you, reading this? Have you been handed a genetic result and felt the walls move in? Have you found your own ways to push back on the framing inside your own care? This is a conversation worth having out loud. Tell me below.

— Dr. Nasha

A few of the anchors beneath this piece, for those who want to follow the thread: the International BRCA1/2 Carrier Cohort Study and the GENE-RAD-RISK study on radiation exposure and breast cancer risk in BRCA carriers; the literature on increased chromosomal radiosensitivity in carriers; multiple cohort analyses finding no significant overall-survival difference by BRCA status; the research on residual fibroglandular tissue after mastectomy and non-zero post-surgical risk; and the Colorado School of Public Health work on heavy metals in San Luis Valley private wells. I write from the data and from the lived experience both. They have never been as separate as we were trained to believe.